핵수용체의 대사 조절 = Metabolic Regulation of Nuclear Receptors

참고문헌 (Reference)

1 Walker BR, "Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease" 1083 : 165-184, 2006

2 Konno Y, "The roles of nuclear receptors CAR and PXR in hepatic energy metabolism" 23 : 8-13, 2008

3 Bosse Y, "The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity" 11 : 809-816, 2003

4 Mitro N, "The nuclear receptor LXR is a glucose sensor" 445 : 219-223, 2007

5 Lakka HM, "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men" 288 : 2709-2716, 2002

6 Erion MD, "Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index" 104 : 15490-15495, 2007

7 Lee YS, "Structure and function of the atypical orphan nuclear receptor small heterodimer partner" 261 : 117-158, 2007

8 Grover GJ, "Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability" 100 : 10067-10072, 2003

9 Cynamon HA, "Rifampin relieves pruritus in children with cholestatic liver disease" 98 : 1013-1016, 1990

10 Shulman AI, "Retinoid X receptor heterodimers in the metabolic syndrome" 353 : 604-615, 2005

11 Hollenberg SM, "Primary structure and expression of a functional human glucocorticoid receptor cDNA" 318 : 635-641, 1985

12 Ford ES, "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey" 287 : 356-359, 2002

13 Torra IP, "Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages" 28 : 2626-2636, 2008

14 Chawla A, "PPARdelta is a very low-density lipoprotein sensor in macrophages" 100 : 1268-1273, 2003

15 Shin DJ, "PGC-1alpha activation of CYP7A1 during food restriction and diabetes is still inhibited by small heterodimer partner" 2008

16 Wang L, "Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis" 20 : 2671-2681, 2006

17 Sonoda J, "Nuclear receptors: decoding metabolic disease" 582 : 2-9, 2008

18 Kodama S, "Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes" 24 : 7931-7940, 2004

19 Grundy SM, "National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition" 109 : 433-438, 2004

20 de Wit NJ, "Muller M, van der Meer R: The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice" 1 : 14-, 2008

21 Moreno M, "Metabolic effects of thyroid hormone derivatives" 18 : 239-253, 2008

22 Nomiyama T, "Liver X receptors as therapeutic targets in metabolism and atherosclerosis" 10 : 88-95+, 2008

23 Makishima M, "Identification of a nuclear receptor for bile acids" 284 : 1362-1365, 1999

24 Cappola AR, "Hypothyroidism and atherosclerosis" 88 : 2438-2444, 2003

25 Ananthanarayanan M, "Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor" 276 : 28857-28865, 2001

26 Zhang W, "FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression" 281 : 10105-10117, 2006

27 Ma K, "Farnesoid X receptor is essential for normal glucose homeostasis" 116 : 1102-1109, 2006

28 Lahtela JT, "Enzyme inducers improve insulin sensitivity in non-insulin -dependent diabetic subjects" 34 : 911-916, 1985

29 Glass CK, "Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers" 15 : 391-407, 1994

30 Odom DT, "Control of pancreas and liver gene expression by HNF transcription factors" 303 : 1378-1381, 2004

31 Duntas LH, "Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?" 17 : 1075-1084, 2007

32 Watanabe M, "Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c" 113 : 1408-1418, 2004

33 Muise ES, "Adipose fibroblast growth factor 21 is up-regulated by PPARγ and altered metabolic states" 2008

34 Oliver WR, Jr., "A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport" 98 : 5306-5311, 2001

35 Park MJ, "A cross-sectional study of socioeconomic status and the metabolic syndrome in Korean adults" 17 : 320-326, 2007